“PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS”. 2018. Genetics & Applications 2 (2): 51-56. https://doi.org/10.31383/ga.vol2iss2pp51-56.